Carolyn Phillips, MSN, RN, ACNP-BC, AOCNP, discusses the unique experienes of young adult patients in their 20x with breast cancer.
Carolyn Phillips, MSN, RN, ACNP-BC, AOCNP, University of Texas at Austin, School of Nursing, discusses the experiences of young woman in their 20s with breast cancer.
Many times, "younger woman with breast cancer" means patients who are younger than age 50. However, developmentally, women in their 50s are different from women in their 40s, their 30s and their 20s. For those in their 20s, the experience can be very unique and leave them feeling isolated -- not a part of the adolescent and young adult patients and not a part of those older women. These patients, therefore, have specific concerns and needs.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.